Clinical Trials Directory

Trials / Terminated

TerminatedNCT00952601

Pilot Study of the Modified Atkins Diet for Tourette Syndrome

Status
Terminated
Phase
Phase 1
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Johns Hopkins University · Academic / Other
Sex
All
Age
12 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Pharmacotherapy has long been considered the primary approach for tic suppression in Tourette syndrome (TS). Unfortunately, medications are often ineffective and frequently have significant side-effects. This is a pilot therapeutic study using a dietary approach, the modified Atkins diet (MAD). The goal of this study is to establish the safety, tolerability, and efficacy of dietary therapy in patients with TS ("proof of concept") and to determine whether this intervention is worthy of evaluation in large-scale clinical trials. The modified Atkins diet mimics the well established ketogenic diet, but in a less-restrictive dietary manner. Dietary approaches using the MAD/ketogenic diet are currently under investigation for neurological conditions other than epilepsy, including Alzheimer disease, headaches, autism, narcolepsy, brain tumors, traumatic brain injury, Parkinson's disease, and depression.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTModified Atkins dietLow carbohydrate diet

Timeline

Start date
2008-09-01
Primary completion
2010-07-01
Completion
2010-07-01
First posted
2009-08-06
Last updated
2010-07-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00952601. Inclusion in this directory is not an endorsement.